Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Helix
  4. Regenerative Scaffolds & Smart Biomaterials

Regenerative Scaffolds & Smart Biomaterials

Dynamic, self-healing scaffolds seeded with autologous stem cells.
Back to HelixView interactive version

Regenerative scaffolds and smart biomaterials are dynamic, self-healing three-dimensional structures seeded with autologous (patient's own) stem cells that can respond to biochemical cues from the host tissue, providing a supportive environment for tissue regeneration that adapts to the changing needs of the healing process. These smart biomaterials can change their properties in response to local conditions, release growth factors or other therapeutic molecules, and provide structural support while promoting tissue regeneration, creating an interactive system that guides and supports the body's natural healing processes. Companies and research institutions are developing these materials for applications in tissue engineering and regenerative medicine.

This innovation addresses the challenge of tissue regeneration, where providing the right environment for cells to grow and organize into functional tissue is critical. By creating responsive, adaptive scaffolds, these materials can better support regeneration. The approach represents an evolution in tissue engineering toward more sophisticated, interactive materials.

The technology is particularly valuable for tissue engineering and regenerative medicine, where creating functional replacement tissues requires sophisticated materials. As the technology improves, it could enable better outcomes in tissue regeneration. However, ensuring biocompatibility, managing complexity, and achieving functional tissue formation remain challenges. The technology represents an important evolution in biomaterials, but requires continued development to achieve the sophistication needed for complex tissue regeneration. Success could enable better tissue engineering outcomes and support regenerative medicine applications, but the path to clinical use requires careful development and validation.

TRL
6/9Demonstrated
Impact
4/5
Investment
3/5
Category
Applications

Related Organizations

EpiBone

United States · Startup

95%

A biotech company growing personalized bone and cartilage grafts using patient stem cells seeded onto 3D scaffolds.

Developer
Humacyte logo
Humacyte

United States · Company

95%

Develops universally implantable bioengineered human tissues, specifically acellular tissue engineered vessels (ATEVs) that act as scaffolds for host cell repopulation.

Developer
Wake Forest Institute for Regenerative Medicine (WFIRM)

United States · University

95%

World-renowned institute that developed the Integrated Tissue and Organ Printing System (ITOP).

Researcher
CollPlant Biotechnologies logo
CollPlant Biotechnologies

Israel · Company

90%

Develops rhCollagen bioinks and partners with 3D Systems to print breast implants and other tissue scaffolds.

Developer
Matricelf

Israel · Startup

90%

Combines hydrogels and cell therapy to manufacture autologous neural implants for spinal cord injury.

Developer
Osteopore

Singapore · Company

90%

Specializes in 3D printed bioresorbable implants that function as scaffolds for natural bone regeneration.

Developer
Wyss Institute for Biologically Inspired Engineering logo
Wyss Institute for Biologically Inspired Engineering

United States · Research Lab

90%

Developed the SWIFT (Sacrificial Writing into Functional Tissue) method for 3D printing vascular channels in living matrices.

Researcher
RegenHU

Switzerland · Company

85%

Manufactures 3D bioprinting systems used to fabricate complex tissue models and regenerative scaffolds.

Developer
Tissium

France · Startup

85%

Develops biomorphic programmable polymers for tissue reconstruction, creating materials that adapt to the tissue environment.

Developer
Secant Group

United States · Company

80%

Engineers advanced biomaterials and textile structures (scaffolds) for the medical device and pharmaceutical industries.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Hardware
Hardware
3D-Bioprinted Vascularized Tissue Constructs

Printers capable of generating functional capillary networks within lab-grown organs.

TRL
4/9
Impact
5/5
Investment
4/5
Applications
Applications
Chinese Stem Cell Tourism

Offshore clinics offering experimental regenerative therapies to global clients.

TRL
4/9
Impact
3/5
Investment
3/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions